Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Polatuzumab_vedotin> ?p ?o }
Showing triples 1 to 43 of
43
with 100 triples per page.
- Polatuzumab_vedotin abstract "Polatuzumab vedotin (RG7596) is a monoclonal antibody designed for the treatment of cancer.This drug was developed by Genentech/Roche.A phase 1 clinical trial in B-cell non-Hodgkin’s lymphoma is registered.".
- Polatuzumab_vedotin atcPrefix "none".
- Polatuzumab_vedotin casNumber "1313206-42-6".
- Polatuzumab_vedotin wikiPageID "46655721".
- Polatuzumab_vedotin wikiPageLength "1954".
- Polatuzumab_vedotin wikiPageOutDegree "5".
- Polatuzumab_vedotin wikiPageRevisionID "707385814".
- Polatuzumab_vedotin wikiPageWikiLink CD79B.
- Polatuzumab_vedotin wikiPageWikiLink Category:Monoclonal_antibodies.
- Polatuzumab_vedotin wikiPageWikiLink Genentech.
- Polatuzumab_vedotin wikiPageWikiLink Hoffmann-La_Roche.
- Polatuzumab_vedotin wikiPageWikiLink Non-Hodgkin_lymphoma.
- Polatuzumab_vedotin wikiPageWikiLinkText "Polatuzumab vedotin".
- Polatuzumab_vedotin atcPrefix "none".
- Polatuzumab_vedotin c "6670".
- Polatuzumab_vedotin casNumber "1313206".
- Polatuzumab_vedotin chemspiderid "none".
- Polatuzumab_vedotin h "10317".
- Polatuzumab_vedotin iupharLigand "8404".
- Polatuzumab_vedotin molecularWeight "149.6".
- Polatuzumab_vedotin n "1745".
- Polatuzumab_vedotin o "2087".
- Polatuzumab_vedotin s "40".
- Polatuzumab_vedotin source "zu/o".
- Polatuzumab_vedotin target CD79B.
- Polatuzumab_vedotin type "mab".
- Polatuzumab_vedotin wikiPageUsesTemplate Template:Drugbox.
- Polatuzumab_vedotin wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Polatuzumab_vedotin wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Polatuzumab_vedotin subject Category:Monoclonal_antibodies.
- Polatuzumab_vedotin hypernym Antibody.
- Polatuzumab_vedotin type ChemicalSubstance.
- Polatuzumab_vedotin type Drug.
- Polatuzumab_vedotin type ChemicalObject.
- Polatuzumab_vedotin type Thing.
- Polatuzumab_vedotin type Q8386.
- Polatuzumab_vedotin comment "Polatuzumab vedotin (RG7596) is a monoclonal antibody designed for the treatment of cancer.This drug was developed by Genentech/Roche.A phase 1 clinical trial in B-cell non-Hodgkin’s lymphoma is registered.".
- Polatuzumab_vedotin label "Polatuzumab vedotin".
- Polatuzumab_vedotin sameAs Q19946115.
- Polatuzumab_vedotin sameAs m.0136_xpc.
- Polatuzumab_vedotin sameAs Q19946115.
- Polatuzumab_vedotin wasDerivedFrom Polatuzumab_vedotin?oldid=707385814.
- Polatuzumab_vedotin isPrimaryTopicOf Polatuzumab_vedotin.